Bio Rad Laboratories reported $375.09M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US USD 5.5B 283M
Agilent A:US USD 1.01B 73M
Becton, Dickinson and BDX:US USD 2.13B 56M
Bio Rad Laboratories BIO:US USD 375.09M 20.89M
Bruker BRKR:US USD 335.1M 35.6M
Charles River Laboratories CRL:US USD 370.22M 13.5M
Danaher DHR:US USD 4.94B 355M
Exact Sciences EXAS:US USD 375.14M 1.9M
Fluidigm FLDM:US USD 9.22M 4.79M
General Electric GE:US USD 5.9B 1.48B
Hologic HOLX:US USD 617.9M 95M
Illumina ILMN:US USD 717M 50M
IQVIA Holdings Inc IQV:US USD 1.24B 31M
Laboratory Of America LH:US USD 1.06B 63M
Merk MRK:US USD 10.47B 610M
Mettler Toledo International MTD:US USD 584.66M 13M
Myriad Genetics MYGN:US USD 106M 23.6M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Perkinelmer PKI:US USD 407.04M 259.12M
Quest Diagnostics DGX:US USD 777M 97M
Repligen RGEN:US USD 114.23M 7.15M
Roche Holding ROG:VX 22.73B 924M
Siemens SIE:GR EUR 7.67B 1.44B
Thermo Fisher Scientific TMO:US USD 4.74B 433M
Tosoh 4042:JP JPY 49.59B 1.29B
Waters WAT:US USD 401.45M 5.66M